Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Biomaterials. 2011 Mar 24;32(19):4369–4375. doi: 10.1016/j.biomaterials.2011.02.049

Figure 5. Gene expression profile after cell-scaffold constructs implanted in vivo.

Figure 5

Figure 5

(A) The expression of SMCs specific markers, including MyoCD, smoothelin, SM22α and SMMHC, was analyzed with quantitative RT-PCR, as shown by indicated times. (B) The expression of pluripotent gene Pou5f1 and other cell lineage specific markers (AFP: endoderm; NeuroD: ectoderm; GATA2: mesoderm). **, p<0.01; ***, p< 0.001.

HHS Vulnerability Disclosure